Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0354 in Patients With Dyslipidemia
NCT00337415Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- May 2006
- Primary completion
- Aug 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0354 in dyslipidemia, sponsored by Merck & Co.. Started May 2006; status: terminated.
02
Drugs
MK-0354
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00337415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337415.